Washington, D.C. (June 8, 2023) – The Alliance of Community Health Plans (ACHP) is the only national payer group pushing for comprehensive drug pricing reform. Allowing Medicare to negotiate for lower prescription drug prices is an important step toward better health care for all. We reaffirm our support for the Inflation Reduction Act’s critical tools to lower drug prices for millions of Americans. Further, we continue to urge Congress to extend the Inflation Reduction Act drug pricing provisions to the commercial market.
###
About ACHP
The Alliance of Community Health Plans (ACHP) represents the nation’s top-performing nonprofit health companies, which serve tens of millions of Americans in nearly 40 states and D.C. ACHP member plans collaborate with providers on high-quality coverage and care — leading the industry in practical reforms.
ACHP is the voice of a unique payer-provider partnership model advancing proven solutions that deliver better value for patients, employers and taxpayers. Contact us for case studies and data about member innovations and results.
New from ACHP:
- ACHP Statement on MAHA Commission
- ACHP Statement on Confirmation of Robert F. Kennedy Jr. as HHS Secretary
- ACHP Letter to CMS on CY 2026 MA and Part D Rate Notice
- ACHP Letter to CMS on Proposed CY 2026 Policy and Technical Changes
- ACHP Letter to National Association of Medicaid Directors
- ACHP Statement on 2027 Medicare Drug Negotiations
